Current Edition


Syneos Health Launches Catalyst Ophthalmology Site Network to Support Faster Start Up and Efficient Trial Delivery

New Network Builds on Success of the Company’s Early Phase, Oncology, Psychiatry and Vaccine Catalyst Site Networks  Syneos Health™ (Nasdaq: SYNH), the only fully integrated …

Continue Reading →

Syneos Health Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution

Syneos Health™, the only fully integrated biopharmaceutical solutions organization, today announced that the company is a founding member of Align Clinical CRO. This new industry …

Continue Reading →